Massachusetts Financial Services
ALXN

Massachusetts Financial Services’s Alexion Pharmaceuticals ALXN Stock Holding History

Massachusetts Financial Services’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-111,383
Closed -$15.6M – 883
2017
Q3 		$15.6M Sell
111,383
-54
-0% -$7.34K 0.01% 533
2017
Q2 		$13.6M Sell
111,437
-532,714
-83% -$62M 0.01% 561
2017
Q1 		$78.1M Sell
644,151
-7,236
-1% -$933K 0.04% 297
2016
Q4 		$79.7M Sell
651,387
-1,017,804
-61% -$125M 0.04% 283
2016
Q3 		$205M Sell
1,669,191
-428,883
-20% -$55.2M 0.1% 187
2016
Q2 		$245M Buy
2,098,074
+368,335
+21% +$52.3M 0.12% 168
2016
Q1 		$241M Sell
1,729,739
-392,606
-18% -$57.6M 0.13% 167
2015
Q4 		$405M Buy
2,122,345
+163,168
+8% +$28.5M 0.22% 126
2015
Q3 		$306M Sell
1,959,177
-189,463
-9% -$34.6M 0.17% 137
2015
Q2 		$388M Sell
2,148,640
-226,610
-10% -$39.1M 0.2% 122
2015
Q1 		$412M Buy
2,375,250
+81,276
+4% +$14.7M 0.21% 111
2014
Q4 		$424M Buy
2,293,974
+166,817
+8% +$30.9M 0.22% 108
2014
Q3 		$353M Buy
2,127,157
+13,164
+0.6% +$2.16M 0.19% 126
2014
Q2 		$330M Buy
2,113,993
+282,872
+15% +$44.7M 0.17% 131
2014
Q1 		$279M Buy
1,831,121
+45,940
+3% +$7.3M 0.15% 144
2013
Q4 		$237M Buy
1,785,181
+426,376
+31% +$51.2M 0.13% 156
2013
Q3 		$158M Buy
1,358,805
+209,018
+18% +$22.9M 0.1% 192
2013
Q2 		$106M Buy
+1,149,787
New +$111M 0.07% 224

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services's ALXN Position: Q4 2017 in Review

Massachusetts Financial Services sold out of Alexion Pharmaceuticals (ALXN) in Q4 2017, closing a stake of 111,383 shares — an estimated $15.6M sold.

Massachusetts Financial Services first reported a position in ALXN in Q2 2013 and held it in 18 quarters. The position peaked at $424M in Q4 2014. 587 funds tracked by Wall St. Rank hold ALXN as of Q4 2017.

  • Massachusetts Financial Services reported no remaining Alexion Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Massachusetts Financial Services sold 111,383 Alexion Pharmaceuticals shares in Q4 2017, an estimated $15.6M.
  • Massachusetts Financial Services first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Massachusetts Financial Services's Alexion Pharmaceuticals position peaked at $424M in Q4 2014.
  • 587 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2017.

Based on Massachusetts Financial Services's 13F filing for Q4 2017, filed 14 Feb 2018.